Cyclopentolate hydrochloride; phenylephrine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for cyclopentolate hydrochloride; phenylephrine hydrochloride and what is the scope of freedom to operate?
Cyclopentolate hydrochloride; phenylephrine hydrochloride
is the generic ingredient in one branded drug marketed by Alcon Labs Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for cyclopentolate hydrochloride; phenylephrine hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 4 |
DailyMed Link: | cyclopentolate hydrochloride; phenylephrine hydrochloride at DailyMed |
Recent Clinical Trials for cyclopentolate hydrochloride; phenylephrine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Milton S. Hershey Medical Center | Phase 4 |
Pontificia Universidad Catolica de Chile | Phase 4 |
University of the Philippines | Phase 4 |
See all cyclopentolate hydrochloride; phenylephrine hydrochloride clinical trials
Pharmacology for cyclopentolate hydrochloride; phenylephrine hydrochloride
Drug Class | alpha-1 Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha1-Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for cyclopentolate hydrochloride; phenylephrine hydrochloride
US Patents and Regulatory Information for cyclopentolate hydrochloride; phenylephrine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon Labs Inc | CYCLOMYDRIL | cyclopentolate hydrochloride; phenylephrine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 084300-001 | Approved Prior to Jan 1, 1982 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.